Bibliometric analysis of research on Alzheimer’s disease and non-coding RNAs: Opportunities and challenges

Xinxing Fei, Shiqi Wang, Jiyang Li, Qiu Zeng, Yaqian Gao, Yue HuFrontiers in Aging Neuroscience 2022 · DOI

TL;DR

This paper provides a comprehensive bibliometric analysis of research at the intersection of Alzheimer's Disease (AD) and non-coding RNAs (ncRNAs). It reveals that this is a rapidly growing field, highlighting key research hotspots, influential institutions and authors, and emerging frontiers that can guide future investigations.

What Problem Does This Paper Address?

Alzheimer's Disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory impairment. Non-coding RNAs (ncRNAs), which do not encode proteins, have emerged as crucial players in various biological processes, including those implicated in AD pathogenesis. While research on AD and ncRNAs has expanded significantly over the past decade, there has been a lack of systematic analysis to map the landscape of this research, identify its trends, and pinpoint future directions. This paper aims to fill that gap by providing a bibliometric and visualization analysis of the existing literature.

Methods

The authors employed a bibliometric approach to analyze research trends, hotspots, and frontiers in the field of AD and ncRNAs. Their methodology involved:

  • Search Strategy: A comprehensive search was conducted on the Web of Science Core Collection (WOSCC) for literature published between 2012 and 2021, using specific keywords related to AD and ncRNAs.
  • Data Collection and Bibliometric Index Statistics: Relevant information from the retrieved articles was exported and analyzed using Excel to count metrics such as annual publications, citation frequency, journal impact factors, and author H-indexes.
  • Visualization Analysis:
    • Co-occurrence and Clustering: CiteSpace software was used for co-occurrence, clustering, and burst analysis of keywords to identify research hotspots and emerging trends.
  • Network Mapping: VOSviewer was utilized to visualize cooperation networks among countries/regions, institutions, and authors.

Datasets

The primary dataset for this study was derived from the Web of Science Core Collection (WOSCC), specifically the Science Citation Index Expanded (SCI-EXPANDED) database, covering publications from 2012 to 2021. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • Rapid Growth: The field of AD and ncRNAs is experiencing a significant and accelerating growth, with a notable surge in publications and citations since 2017. This indicates a burgeoning interest and investment in this research area.
  • Journal of Alzheimer's Disease Dominance: The Journal of Alzheimer's Disease stands out as the most popular journal for publishing research in this field, underscoring its central role in disseminating findings related to AD.
  • China's Productivity vs. Influence: While China leads in the sheer volume of publications, its average citation count is lower compared to other leading countries. This suggests an opportunity for China to enhance the global impact and influence of its research in this domain.
  • US Leadership in Cooperation: The United States not only ranks high in publications but also demonstrates the most extensive international cooperation, highlighting its central role in driving global research efforts.
  • Key Research Focus: The primary research hotspots revolve around the role and mechanisms of ncRNAs, particularly microRNAs (miRNAs), in AD. The research is largely foundational, focusing on animal and cellular models, and often intersects with proteomics.
  • Emerging Frontiers: "Circular RNAs," "regulation of neuroinflammation," and "tau protein" are identified as key future research directions, suggesting these areas hold significant promise for advancing our understanding and treatment of AD.

Key Results

  • Publication Volume: A total of 1,613 publications were identified within the last decade.
  • Document Types: Articles and reviews constitute the vast majority of publications (70% and 24%, respectively).
  • Top Countries: China (632 publications) leads in publication volume, followed by the United States (446) and Italy (102).
  • Top Institutions: Louisiana State University System (66 publications) is the most prolific institution, with Harvard University (average citations = 56.03) receiving the highest average citations.
  • Top Authors: Lukiw WJ is the most productive author (56 publications), while Reddy PH has the highest average citations (49.17).
  • Journal Landscape: The Journal of Alzheimer's Disease published the most articles (68), followed by Molecular Neurobiology (59) and International Journal of Molecular Sciences (50).
  • Keyword Hotspots: Key co-occurring keywords include "brain," "microRNAs," "amyloid precursor protein," "biomarker," and "amyloid beta," indicating a focus on the molecular mechanisms and diagnostic potential of ncRNAs in AD.

Limitations and Future Work

The authors acknowledge several limitations:

  • Search Strategy Incompleteness: The search strategy, while comprehensive, may not capture all relevant literature, especially if authors publish in document types not covered by the chosen database or if they use less common terminology.
  • Author Name Ambiguity: Potential biases can arise from authors with the same name or changes in institutional affiliations.
  • Incomplete Year Data: The analysis for 2022 is incomplete due to the year not having concluded, potentially affecting the accuracy of recent trend analysis.

Future work suggested by the paper includes:

  • Deepening International Cooperation: Strengthening international collaboration, particularly for countries like China with high productivity but lower global influence, is crucial.
  • Exploring Emerging Frontiers: Further research into circular RNAs, the regulation of neuroinflammation by ncRNAs, and the role of tau protein in AD pathogenesis is highly recommended.
  • Investigating Specific ncRNA Mechanisms: Understanding how specific ncRNAs modulate cellular processes like apoptosis, neuroprotection, and neuroinflammation in AD is a key area for future investigation.
  • Translational Research: While much research is basic, there's a clear need to translate these findings into potential diagnostic biomarkers and therapeutic targets for AD.

Summary updated

Abstract

Taken together, the field of AD and ncRNAs is developing well. The research hotspots and frontiers in this field can provide a reference for researchers to choose their research direction.
BibTeX
@inproceedings{fei2022bibliometric,
  author = {Xinxing Fei and Shiqi Wang and Jiyang Li and Qiu Zeng and Yaqian Gao and Yue Hu},
  title = {{Bibliometric analysis of research on Alzheimer’s disease and non-coding RNAs: Opportunities and challenges}},
  booktitle = {Frontiers in Aging Neuroscience},
  year = {2022},
  doi = {10.3389/fnagi.2022.1037068},
}
Figure